Survival analysis of Fbln2 showed different prognosis of breast cancer at different stages of tumor development, where higher Fbln2 was associated with a better prognosis in early stages; however, low Fbln2 was associated with a better prognosis in advanced breast cancer. Here, FBLN2 is linked to neoplasm.